Sheppard Mullin advised Decoy Biosystems , Inc. on the deal. Decoy Biosystems, Inc., a privately held, preclinical-stage biotechnology company developing novel, multi-targeted products that safely prime...
Sheppard Mullin advised Decoy Biosystems , Inc. on the deal. Decoy Biosystems, Inc., a privately held, preclinical-stage biotechnology company developing novel, multi-targeted products that safely prime...